These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19194904)

  • 1. Physicochemical characterization of siRNA-peptide complexes.
    Law M; Jafari M; Chen P
    Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
    Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
    J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine.
    Choi YS; Lee JY; Suh JS; Kwon YM; Lee SJ; Chung JK; Lee DS; Yang VC; Chung CP; Park YJ
    Biomaterials; 2010 Feb; 31(6):1429-43. PubMed ID: 19954842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity.
    Matsui K; Horiuchi S; Sando S; Sera T; Aoyama Y
    Bioconjug Chem; 2006; 17(1):132-8. PubMed ID: 16417261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAMAM dendrimers for siRNA delivery: computational and experimental insights.
    Pavan GM; Posocco P; Tagliabue A; Maly M; Malek A; Danani A; Ragg E; Catapano CV; Pricl S
    Chemistry; 2010 Jul; 16(26):7781-95. PubMed ID: 20496352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents.
    Perez AP; Romero EL; Morilla MJ
    Int J Pharm; 2009 Oct; 380(1-2):189-200. PubMed ID: 19577619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.
    Mok H; Park TG
    Biopolymers; 2008 Oct; 89(10):881-8. PubMed ID: 18521895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference.
    Endoh T; Sisido M; Ohtsuki T
    Bioconjug Chem; 2008 May; 19(5):1017-24. PubMed ID: 18442282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted quantum dot conjugates for siRNA delivery.
    Derfus AM; Chen AA; Min DH; Ruoslahti E; Bhatia SN
    Bioconjug Chem; 2007; 18(5):1391-6. PubMed ID: 17630789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducible poly(amido ethylenimine) directed to enhance RNA interference.
    Hoon Jeong J; Christensen LV; Yockman JW; Zhong Z; Engbersen JF; Jong Kim W; Feijen J; Wan Kim S
    Biomaterials; 2007 Apr; 28(10):1912-7. PubMed ID: 17218006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
    Kim J; Lee SH; Choe J; Park TG
    J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.